Clinical trial
Telbivudine in Adults Previously Treated in Idenix-Sponsored Telbivudine Studies
NCT00142298 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00142298 |
|---|---|
| Title | Telbivudine in Adults Previously Treated in Idenix-Sponsored Telbivudine Studies |
| Official title | An Open Label Trial of Telbivudine (LdT) in Adults With Chronic Hepatitis B Previously Treated in Idenix-Sponsored Telbivudine Studies |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Collaborators | Merck Sharp & Dohme LLC Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Hepatitis B |
| Intervention type | Drug |
| Interventions | Telbivudine (LdT) |
| Enrollment | 1,869 |
| Start date | Mar 1, 2005 |
| Primary completion | Nov 1, 2009 |
| Completion | Nov 1, 2009 |
| First posted | Sep 2, 2005 |
| Last update posted | Aug 21, 2020 |
| Countries | Australia, Canada, China, Czechia, France, Germany, Hong Kong, India, Israel, Italy, New Zealand, Poland and 9 more |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: